Loss of p21 WAFIIcIPI expression correlates with disease progression in gastric carcinoma
1997

Loss of p21 Expression in Gastric Carcinoma and Its Correlation with Disease Progression

Sample size: 172 publication Evidence: moderate

Author Information

Author(s): M Ogawa, K Maeda, N Onoda, Y-S Chung, M Sowa

Primary Institution: Osaka City University Medical School

Hypothesis

Does the loss of p21 protein expression correlate with disease progression in gastric carcinoma?

Conclusion

Loss of p21 expression in primary gastric carcinoma correlates with disease progression and indicates a poorer prognosis.

Supporting Evidence

  • 60.4% of the tumor tissues showed loss of p21 expression.
  • Patients with p21-negative tumors had a significantly higher risk of recurrence after surgery.
  • Loss of p21 expression was more frequent in patients with lymph node, liver, or peritoneal metastases.

Takeaway

This study found that when a protein called p21 is missing in stomach cancer, the disease tends to get worse and patients do not do as well.

Methodology

Immunohistochemical staining was used to assess p21 protein expression in 172 primary gastric carcinoma specimens.

Limitations

The study is retrospective and may not account for all variables affecting prognosis.

Participant Demographics

The study included 110 men and 62 women, aged 28 to 82 years, with an average age of 59.5 years.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication